Biogen to Participate in the Stifel 2026 Virtual CNS Forum

robot
Abstract generation in progress

Biogen announced that Diana Gallagher, M.D., and Stephanie Fradette, PharmD, will participate in a fireside chat at the Stifel 2026 Virtual CNS Forum on March 18, 2026, at 9:30 a.m. ET. The event will be webcast live on Biogen’s investor website, with an archived version available for 30 days. Biogen, a biotechnology company founded in 1978, focuses on developing innovative medicines.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin